tm
Seeing Is Believing
tm
Seeing Is Believing
Neoleukin Therapeutics's activity chart (see below) currently has 17 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 93.33% with an average time for these price targets to be met of 409.1 days.
Most recent stock forecast was given by from MIZUHO on 09-May-2023. First documented stock forecast 17-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Nov-2022
$7.5
$-7.6 (-50.33%)
3 years 2 months 10 days ago
(09-May-2023)
2/2 (100%)
$-10.3 (-57.87%)
371
Hold Since 16-Nov-2022
3 years 8 months 3 days ago
(16-Nov-2022)
1/1 (100%)
$-130.4 (-54.24%)
584
Buy Since 06-Jan-2021
$4.5
$-10.6 (-70.20%)
3 years 8 months 4 days ago
(15-Nov-2022)
2/2 (100%)
$-4 (-47.06%)
379
Hold Since 15-Nov-2022
$100
3 years 8 months 4 days ago
(15-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
Sell Since 12-Sep-2022
$15
$-0.1 (-0.66%)
$90
3 years 10 months 7 days ago
(12-Sep-2022)
2/2 (100%)
$-6.4 (-29.91%)
335
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NLTX (Neoleukin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?
